Prestige Consumer Healthcare Inc. PBH delivered second-quarter fiscal 2020 results, with the top and the bottom line surpassing the Zacks Consensus Estimate for the third straight time. Earnings also improved year on year. However, the top line in the reported quarter was adversely impacted by inventory reductions.
The company posted adjusted earnings of 68 cents per share, which outpaced the Zacks Consensus Estimate of 65 cents. This marked its seventh consecutive quarter of earnings beat. Quarterly earnings also improved 4.6% year over year.
Total revenues of $238.1 million exceeded the Zacks Consensus Estimate of $237.2 million. However, the top line inched down 0.5% year over year, while organic revenues (excluding currency effects) remained flat. Top-line results were affected by retailer inventory reductions, which were largely mitigated by robust consumption trends at core categories and solid international unit.
Prestige Consumer Healthcare Inc. Price, Consensus and EPS Surprise
Prestige Consumer Healthcare Inc. price-consensus-eps-surprise-chart | Prestige Consumer Healthcare Inc. Quote
Gross profit came in at $136.8 million, which inched down 0.5% from the prior-year quarter’s figure. Gross margin remained flat year on year at 57.4%. Nevertheless, adjusted gross margin improved 60 basis points (bps) to 58%, primarily driven by product mix.
Adjusted EBITDA was $77.1 million, down 3.7% year over year. Adjusted EBITDA margin contracted 110 bps to 32.4%.
Revenues in the North American OTC Healthcare segment were $213.9 million, down nearly 1% year over year. The decline is accountable to inventory reductions, compensated by increased consumption at core categories.
Revenues in the International OTC Healthcare segment totaled $24.2 million, up 3.4% from the year-ago quarter’s figure. The upside can be attributed to increased consumption as well as timing of shipments and distributor orders, which were partly negated by currency headwinds to the tune of $1 million.
The company exited the quarter under review with cash and cash equivalents of $27.9 million, long-term debt (net) of $1,754.1 million and total shareholders’ equity of $1,112.7 million.
During the second quarter, the company lowered its debt by $46 million in the second quarter and repurchased shares worth roughly $50 million. Net cash provided by operating activities in the reported quarter was $50.2 million. Accordingly, cash flow from operations in the first six months of 2020 amounted to $103 million.
As of Sep 30, 2019, the company’s net debt position was about $1.7 billion.
Prestige Consumer is optimistic regarding consumption trends across core brands. Management stated that the invest-for-growth strategy has been yielding well. The company is also on track to transition to a new third-party logistics provider. Further the company is on track with its core strategies, efforts to maintain a strong financial profile and maximize capital allocation.
For fiscal 2020, the company lowered its revenue expectation, mainly due to anticipated impacts from currency movements. It now anticipates revenues in the range of $947-$957 million compared with the earlier view of $951-$961 million. Nevertheless, it reiterated organic revenue expectations and expects it to stay flat.
Further, adjusted earnings per share are still envisioned in the range of $2.76-$2.83. In this regard, it had earlier highlighted that adjusted earnings will be more weighted in the second half of fiscal 2020 due to increased A&P and G&A spending in the first half.
Free cash flow is forecasted to be $200 million or more in fiscal 2020.
The Zacks Rank #2 (Buy) stock has gained 5.4% in the past three months against the industry’s decline of 3.2%.
Looking for More Consumer Discretionary Picks? Check These
Guess? GES has a long-term earnings growth rate of 17.5%. It currently has a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank(Strong Buy) stocks here.
lululemon athletica LULU has a long-term earnings growth rate of 18.2% and a Zacks Rank #2.
Columbia Sportswear COLM has a long-term earnings growth rate of 11.2% and a Zacks Rank #2.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.
Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.5% per year. So be sure to give these hand-picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Prestige Consumer Healthcare Inc. (PBH) : Free Stock Analysis Report
lululemon athletica inc. (LULU) : Free Stock Analysis Report
Columbia Sportswear Company (COLM) : Free Stock Analysis Report
Guess?, Inc. (GES) : Free Stock Analysis Report
To read this article on Zacks.com click here.